Robert Ching Chan, MD
Urology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 2 carriers
- Office
- 1
- Since medical school
- 19 years
- Vanderbilt University School of Medicine, 2007
Offices
1 location · Regents Univ of California UCSF · 276 clinicians in this group
Hospitals listed: Marinhealth Medical Center · Novato Community Hospital · Petaluma Valley Hospital · Sonoma Valley Hospital. That is not proof they admit you there this week.
Plans that list them
11 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chan’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
11 of 11 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A157982 · Current
Licensed to practise in California · since 2018 · expires 2028-08-31 · Vanderbilt University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Texas BP10029337Physician-in-Training Permit · since 2007 · expires 2012-06-23Permit TerminatedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Urology - Urology
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- Novato Community HospitalNovato, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Petaluma Valley HospitalPetaluma, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Sonoma Valley HospitalSonoma, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Novato Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 213 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.4 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.1 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 627 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,872 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,796 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.92 (0.5 to 5.33) · 505 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.51 to 3.88) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.93 (0 to 17.29) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 311 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,320 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 143 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 121 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.1 · 150 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.5 to 16.5) · 930 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 184 cases | No different | Jan 2024 – Dec 2024 |
What patients said (334 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Petaluma Valley Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 6 the same, 1 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.31 (0.23 to 2.39) · 147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.44 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 49 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.6 · 118 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 154 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.7 · 57 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 533 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,427 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,398 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.64 to 5.65) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.56 to 3.98) · 202 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.61 (0 to 18.36) · 49 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.16 (0.85 to 9.47) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.25) · 45 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.37 (0 to 1.41) · 1,184 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 6.1 · 26 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.308 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.6 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -3 · 143 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 131 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 26 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 52 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.3 (9.8 to 17.8) · 364 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 138 cases | No different | Jan 2024 – Dec 2024 |
What patients said (246 patients answered, 23% of those asked)
| Cleanliness | 5 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 85% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sonoma Valley Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 6 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.11 (0.63 to 1.6) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 37 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.6 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 35 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.6 · 345 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 713 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 660 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.36 (0.77 to 5.94) · 101 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.38) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.58 to 4.03) · 100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.86 (0 to 18.76) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (0.84 to 9.45) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.12 (0 to 2.33) · 540 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 60 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 15.5 · 47 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 105 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 47 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.2 to 17.9) · 486 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 83 cases | No different | Jan 2024 – Dec 2024 |
What patients said (164 patients answered, 31% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 85% |
| Doctors "always" communicated well | 88% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 84% |
| Doctors "always" listened carefully | 88% |
| Doctors "always" treated them with courtesy and respect | 92% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 81% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 91% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$237,332
Medicare paid this office $237,332 for 836 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 394 | $35,682 | $71 |
| New patient visit (45+ min) | 229 | $30,357 | $133 |
| Diagnostic exam of bladder and urethra using an endoscope | 115 | $28,213 | $203 |
| Return visit (30+ min) | 229 | $26,455 | $100 |
| Botox | 24 | $14,203 | None |
See all 19 services
| Short return visit (20+ min) | 394 | $35,682 | $71 |
| New patient visit (45+ min) | 229 | $30,357 | $133 |
| Diagnostic exam of bladder and urethra using an endoscope | 115 | $28,213 | $203 |
| Return visit (30+ min) | 229 | $26,455 | $100 |
| Botox | 24 | $14,203 | None |
| Exam with injections of chemical for destruction of bladder using an endoscope | 24 | $10,268 | $342 |
| Insertion of lower leg neurostimulator electrode | 23 | $9,211 | $100 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 14 | $8,650 | $618 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 20 | $6,821 | $341 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 50 | $6,620 | $66 |
| Destruction of prostate tissue using radiofrequency induced heated water vapor | 21 | $6,459 | $308 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 57 | $6,018 | $100 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | 12 | $2,746 | $196 |
| Insertion of stent in ureter using an endoscope | 20 | $1,915 | $96 |
| Ultrasound measurement of bladder capacity after voiding | 169 | $1,673 | $9 |
| Simple insertion of temporary bladder tube | 16 | $1,429 | $57 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $979 | $75 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 11 | $579 | $28 |
| Imaging of urinary tract following injection of a contrast agent | 25 | $514 | $21 |
Procedures Medicare counted
| Prostate resection | 27 | More than 88% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Ultrasound measurement of bladder capacity after voiding | 121 | 103 | 122 | 141 | 147 | 185 |
| Diagnostic exam of bladder and urethra using an endoscope | 69 | 71 | 136 | 123 | 186 | 139 |
| Insertion of lower leg neurostimulator electrode | – | 51 | 101 | – | – | 92 |
| Simple insertion of temporary bladder tube | 18 | 30 | 27 | 41 | 39 | 25 |
| Exam with injections of chemical for destruction of bladder using an endoscope | – | 20 | 20 | 34 | 33 | 30 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 16 | 11 | 17 | 21 | 16 | 20 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
836 Original Medicare patients in 2024. Average age 77 · Under 65 3% · 85 and older 16% · Women 30% · Also on Medicaid 14% · Health risk score 1.24. At or below the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 70% · Coronary heart disease 34% · Chronic kidney disease 25% · Cancer 24% · Atrial fibrillation 23% · Diabetes 22% · Depression 21% · Heart failure 14% · Stroke 13% · COPD 11% · Dementia 7%.
The office billed $1,613,138, Medicare allowed $320,339 and paid $237,332; for 5,118 services of 74 kinds; $24,969 of it was for drugs given in the office and $212,363 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 836 | 5,118 | 77 | 1.24 | $1,613,138 | $237,332 |
| 2023 | 928 | 7,306 | 76 | 1.22 | $2,009,892 | $298,302 |
| 2022 | 707 | 6,091 | 76 | 1.19 | $1,619,051 | $245,269 |
| 2021 | 579 | 5,479 | 76 | 1.25 | $1,493,557 | $221,137 |
| 2020 | 422 | 4,269 | 76 | 1.32 | $947,934 | $134,609 |
| 2019 | 506 | 2,890 | 75 | 1.37 | $817,212 | $137,337 |
| 2018 | 538 | 10,316 | 74 | 1.43 | $470,608 | $157,180 |
| 2017 | 489 | 10,878 | 74 | 1.45 | $386,934 | $126,870 |
| 2016 | 439 | 10,724 | 73 | 1.34 | $390,780 | $129,463 |
| 2015 | 469 | 6,818 | 73 | 1.40 | $394,051 | $130,338 |
| 2014 | 172 | 792 | 73 | 1.35 | $116,168 | $39,034 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 24 services
| Return visit (30+ min) | 339 | $42,997 | $98 |
| Diagnostic exam of bladder and urethra using an endoscope | 149 | $40,015 | $215 |
| New patient visit (45+ min) | 296 | $37,537 | $127 |
| Short return visit (20+ min) | 395 | $34,670 | $70 |
| Botox | 29 | $19,819 | None |
| Leuprolide acetate (for depot suspension), 7.5 mg | 23 | $19,651 | None |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 21 | $12,956 | $617 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 28 | $11,856 | $359 |
| Insertion of sacral nerve neurostimulator electrode array | 20 | $7,950 | $379 |
| Destruction of prostate tissue using radiofrequency induced heated water vapor | 22 | $7,246 | $329 |
| Insertion of sacral nerve neurostimulator electrode | 13 | $7,180 | $552 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 15 | $5,795 | $362 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 44 | $5,049 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $4,371 | $67 |
| Simple change of bladder tube | 11 | $2,510 | $74 |
| Simple insertion of temporary bladder tube | 23 | $2,011 | $52 |
| Urinalysis, manual test | 319 | $1,528 | $3 |
| Ultrasound measurement of bladder capacity after voiding | 137 | $1,363 | $9 |
| Insertion or replacement of peripheral, sacral, or gastric neurostimulator generator or receiver | 15 | $1,286 | $86 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $1,056 | $75 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 23 | $1,002 | $25 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 13 | $438 | $34 |
| Imaging of urinary tract following injection of a contrast agent | 18 | $396 | $21 |
| Imaging guidance for procedure, 60 minutes or less | 15 | $233 | $13 |
2022: 20 services
| New patient visit (45+ min) | 302 | $42,453 | $141 |
| Return visit (30+ min) | 243 | $34,936 | $114 |
| Short return visit (20+ min) | 285 | $29,137 | $79 |
| Diagnostic exam of bladder and urethra using an endoscope | 107 | $26,211 | $213 |
| Botox | 24 | $16,283 | None |
| Exam with injections of chemical for destruction of bladder using an endoscope | 26 | $12,424 | $365 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 16 | $9,603 | $600 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 20 | $7,491 | $357 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $5,067 | $59 |
| Insertion of sacral nerve neurostimulator electrode array | 13 | $4,947 | $381 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 41 | $4,406 | $107 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 12 | $3,537 | $295 |
| Simple change of bladder tube | 14 | $2,310 | $75 |
| Telephone medical discussion with physician, 11-20 minutes | 23 | $2,128 | $93 |
| Simple insertion of temporary bladder tube | 24 | $1,972 | $48 |
| Urinalysis, manual test | 369 | $1,752 | $3 |
| Ultrasound measurement of bladder capacity after voiding | 128 | $1,172 | $8 |
| Imaging of urinary tract following injection of a contrast agent | 20 | $420 | $21 |
| Injection of drug or substance under skin or into muscle | 14 | $366 | $13 |
| Imaging guidance for procedure, 60 minutes or less | 16 | $280 | $13 |
2021: 19 services
| New patient visit (45+ min) | 303 | $39,215 | $129 |
| Diagnostic exam of bladder and urethra using an endoscope | 123 | $30,055 | $221 |
| Return visit (30+ min) | 212 | $28,125 | $105 |
| Short return visit (20+ min) | 205 | $20,148 | $77 |
| Insertion of lower leg neurostimulator electrode | 19 | $12,092 | $120 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 17 | $10,752 | $632 |
| Botox | 15 | $10,612 | None |
| Exam with injections of chemical for destruction of bladder using an endoscope | 15 | $7,247 | $362 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 16 | $5,935 | $349 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,477 | $116 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 11 | $3,164 | $288 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,836 | $62 |
| Urinalysis, manual test | 343 | $1,807 | $3 |
| Simple change of bladder tube | 13 | $1,621 | $85 |
| Simple insertion of temporary bladder tube | 15 | $1,443 | $53 |
| Insertion of stent in ureter using an endoscope | 14 | $1,220 | $87 |
| Ultrasound measurement of bladder capacity after voiding | 114 | $1,053 | $9 |
| Insertion of temporary bladder tube | 18 | $761 | $40 |
| Imaging of urinary tract following injection of a contrast agent | 19 | $433 | $22 |
2020: 16 services
| New patient visit (45+ min) | 174 | $21,686 | $125 |
| Short return visit (20+ min) | 216 | $19,639 | $59 |
| Diagnostic exam of bladder and urethra using an endoscope | 67 | $13,198 | $186 |
| Botox | 16 | $10,571 | None |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 11 | $6,559 | $596 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 16 | $6,556 | $328 |
| Insertion of lower leg neurostimulator electrode | 12 | $5,792 | $114 |
| Return visit (30+ min) | 51 | $5,369 | $89 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 11 | $3,954 | $359 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,967 | $175 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,891 | $118 |
| Simple insertion of temporary bladder tube | 14 | $1,494 | $50 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,251 | $63 |
| Urinalysis, manual test | 230 | $1,063 | $3 |
| Ultrasound measurement of bladder capacity after voiding | 95 | $838 | $8 |
| Short return visit | 15 | $666 | $42 |
2019: 16 services
| New patient visit (45+ min) | 177 | $22,720 | $128 |
| Short return visit (20+ min) | 238 | $15,795 | $50 |
| Diagnostic exam of bladder and urethra using an endoscope | 65 | $10,011 | $145 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 15 | $6,045 | $378 |
| Return visit (30+ min) | 39 | $3,448 | $84 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 32 | $3,307 | $100 |
| New patient visit (30+ min) | 30 | $2,478 | $83 |
| Insertion of device into abdomen with pressure and urine flow rate study | 18 | $1,986 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $1,327 | $53 |
| Ultrasound measurement of bladder capacity after voiding | 108 | $1,258 | $10 |
| Simple insertion of temporary bladder tube | 11 | $964 | $54 |
| Urinalysis, manual test | 145 | $600 | $3 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 19 | $538 | $28 |
| Manual urinalysis test with examination using microscope, automated | 61 | $242 | $3 |
| Automated urinalysis test | 65 | $185 | $2 |
| Insertion of needle into vein for collection of blood sample | 43 | $132 | $3 |
2018: 20 services
| Short return visit (20+ min) | 262 | $21,766 | $50 |
| New patient visit (45+ min) | 142 | $15,338 | $108 |
| Diagnostic exam of bladder and urethra using an endoscope | 57 | $9,006 | $127 |
| Return visit (30+ min) | 96 | $8,256 | $75 |
| Creation of sling around urethra in female to control leakage | 14 | $7,502 | $536 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 50 | $5,095 | $98 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 15 | $3,863 | $258 |
| Insertion of lower leg neurostimulator electrode | 14 | $3,855 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,414 | $55 |
| Insertion of device into abdomen with pressure and urine flow rate study | 22 | $1,912 | $87 |
| Ultrasound measurement of bladder capacity after voiding | 109 | $1,630 | $11 |
| Injection procedure for imaging of bladder during voiding | 23 | $1,615 | $70 |
| Manual urinalysis test with examination using microscope, automated | 252 | $1,517 | $4 |
| Injection of drug or substance under skin or into muscle | 22 | $1,389 | $14 |
| Simple bladder irrigation and/or instillation | 15 | $963 | $57 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 22 | $588 | $27 |
| Insertion of needle into vein for collection of blood sample | 95 | $344 | $3 |
| Automated urinalysis test | 67 | $233 | $3 |
| Electronic assessment of bladder emptying | 20 | $121 | $6 |
| Injection, ceftriaxone sodium, per 250 mg | 11 | $21 | None |
2017: 19 services
| Short return visit (20+ min) | 279 | $21,988 | $50 |
| New patient visit (45+ min) | 134 | $15,056 | $112 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 36 | $9,222 | $249 |
| Insertion of lower leg neurostimulator electrode | 14 | $7,532 | $89 |
| Diagnostic exam of bladder and urethra using an endoscope | 34 | $5,038 | $123 |
| Return visit (30+ min) | 60 | $4,874 | $77 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 44 | $4,786 | $102 |
| Insertion of device into abdomen with pressure and urine flow rate study | 35 | $3,042 | $84 |
| Injection procedure for imaging of bladder during voiding | 36 | $2,552 | $69 |
| Injection of drug or substance under skin or into muscle | 16 | $2,066 | $17 |
| Manual urinalysis test with examination using microscope, automated | 301 | $1,909 | $4 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $1,647 | $48 |
| Ultrasound measurement of bladder capacity after voiding | 77 | $1,073 | $13 |
| Insertion of stent in ureter using an endoscope | 13 | $981 | $75 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 36 | $950 | $26 |
| Simple insertion of temporary bladder tube | 11 | $505 | $42 |
| Insertion of needle into vein for collection of blood sample | 73 | $300 | $3 |
| Electronic assessment of bladder emptying | 36 | $229 | $6 |
| Imaging of urinary tract following injection of a contrast agent | 14 | $206 | $13 |
2016: 21 services
| Short return visit (20+ min) | 214 | $15,801 | $49 |
| New patient visit (45+ min) | 106 | $11,047 | $104 |
| Return visit (30+ min) | 86 | $7,402 | $73 |
| Insertion of lower leg neurostimulator electrode | 16 | $7,277 | $90 |
| Diagnostic exam of bladder and urethra using an endoscope | 47 | $7,256 | $148 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $2,681 | $103 |
| Injection of drug or substance under skin or into muscle | 25 | $1,944 | $18 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $1,851 | $51 |
| New patient visit (60+ min) | 13 | $1,827 | $141 |
| Ultrasound measurement of bladder capacity after voiding | 103 | $1,759 | $13 |
| Long return visit (40+ min) | 18 | $1,751 | $97 |
| Manual urinalysis test with examination using microscope, automated | 268 | $1,653 | $4 |
| Simple bladder irrigation and/or instillation | 18 | $1,198 | $60 |
| Insertion of device into abdomen with pressure and urine flow rate study | 14 | $1,165 | $83 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 13 | $933 | $72 |
| Injection procedure for imaging of bladder during voiding | 14 | $886 | $63 |
| Simple insertion of temporary bladder tube | 11 | $733 | $52 |
| Short return visit | 13 | $357 | $27 |
| Automated urinalysis test | 41 | $144 | $3 |
| Electronic assessment of bladder emptying | 14 | $84 | $6 |
| Insertion of needle into vein for collection of blood sample | 27 | $81 | $3 |
2015: 23 services
| Short return visit (20+ min) | 216 | $17,549 | $52 |
| New patient visit (45+ min) | 128 | $14,615 | $114 |
| Return visit (30+ min) | 114 | $10,122 | $75 |
| Insertion of lower leg neurostimulator electrode | 13 | $9,741 | $89 |
| Diagnostic exam of bladder and urethra using an endoscope | 56 | $8,931 | $144 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 22 | $4,833 | $210 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 14 | $4,557 | $325 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 33 | $3,493 | $100 |
| Long return visit (40+ min) | 19 | $2,092 | $110 |
| New patient visit (60+ min) | 12 | $1,889 | $157 |
| Insertion of device into abdomen with pressure and urine flow rate study | 24 | $1,833 | $73 |
| Ultrasound measurement of bladder capacity after voiding | 94 | $1,522 | $13 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 24 | $1,508 | $63 |
| Manual urinalysis test with examination using microscope, automated | 244 | $1,377 | $4 |
| Injection procedure for imaging of bladder during voiding | 19 | $1,301 | $65 |
| Injection of drug or substance under skin or into muscle | 24 | $1,143 | $18 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,112 | $56 |
| Simple insertion of temporary bladder tube | 18 | $1,044 | $47 |
| Simple bladder irrigation and/or instillation | 13 | $878 | $63 |
| Insertion of needle into vein for collection of blood sample | 61 | $223 | $3 |
| Automated urinalysis test | 60 | $210 | $3 |
| Manual urinalysis test with examination using microscope, non-automated | 43 | $190 | $4 |
| Electronic assessment of bladder emptying | 24 | $131 | $5 |
2014: 9 services
| Short return visit (20+ min) | 90 | $6,194 | $53 |
| New patient visit (45+ min) | 48 | $5,429 | $113 |
| Return visit (30+ min) | 31 | $2,766 | $79 |
| Diagnostic exam of bladder and urethra using an endoscope | 16 | $2,408 | $151 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,367 | $105 |
| Ultrasound measurement of bladder capacity after voiding | 53 | $807 | $13 |
| Manual urinalysis test with examination using microscope, automated | 111 | $628 | $4 |
| Short return visit | 16 | $518 | $30 |
| Insertion of needle into vein for collection of blood sample | 29 | $94 | $3 |
Medicaid work
$3,776 in 2024
Medicaid paid $3,776 for 68 billed services this clinician did in 2024, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 24 | $2,150 |
| Short return visit (20+ min) | 44 | $1,626 |
| 2024 | 68 | 2 | 16 | $3,776 |
| 2023 | 381 | 4 | 28 | $15,699 |
| 2022 | 227 | 4 | 20 | $7,606 |
| 2021 | 206 | 3 | 21 | $8,224 |
| 2020 | 100 | 3 | 21 | $3,365 |
See the largest Medicaid services in earlier years
2023
| New patient visit (45+ min) | 97 | $10,480 |
| Return visit (30+ min) | 70 | $3,597 |
| Short return visit (20+ min) | 46 | $1,141 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 168 | $481 |
2022
| New patient visit (45+ min) | 68 | $6,613 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 132 | $380 |
| Return visit (30+ min) | 13 | $347 |
| Short return visit (20+ min) | 14 | $266 |
2021
| New patient visit (45+ min) | 88 | $7,735 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 106 | $249 |
| Short return visit (20+ min) | 12 | $240 |
2020
| New patient visit (45+ min) | 31 | $2,646 |
| Short return visit (20+ min) | 27 | $622 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 42 | $98 |
Drugs they prescribed that Part D paid
$145,578
Pharmacies billed $145,578 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (62 of 1,509) in 2024. Above the middle of the specialty; the typical urology clinician is at 2%.
1,356 generic and fewer than 11 brand-name prescriptions · $145,578 in drug cost · 380 antibiotic prescriptions to 249 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 49 | $53,032 | $1,082 |
| Gemtesa | 58 | $48,726 | $840 |
| Methenamine Hippurate | 73 | $8,759 | $120 |
| Tamsulosin | 416 | $7,112 | $17 |
| Oxybutynin Chloride Er | 102 | $3,156 | $31 |
See all 20 drugs
| Myrbetriq | 49 | $53,032 | $1,082 |
| Gemtesa | 58 | $48,726 | $840 |
| Methenamine Hippurate | 73 | $8,759 | $120 |
| Tamsulosin | 416 | $7,112 | $17 |
| Oxybutynin Chloride Er | 102 | $3,156 | $31 |
| Finasteride | 115 | $1,969 | $17 |
| Estradiol | 24 | $1,700 | $71 |
| Nitrofurantoin Mono-Macro | 89 | $1,530 | $17 |
| Testosterone Cypionate | 21 | $1,257 | $60 |
| Cephalexin | 51 | $689 | $14 |
| Alfuzosin Hcl Er | 14 | $516 | $37 |
| Sulfamethoxazole-Trimethoprim | 129 | $490 | $4 |
| Desmopressin Acetate | 12 | $475 | $40 |
| Ciprofloxacin | 60 | $248 | $4 |
| Hydrocodone-Acetaminophen | 23 | $211 | $9 |
| Doxazosin Mesylate | 12 | $176 | $15 |
| Amoxicillin-Clavulanate Potass | 21 | $164 | $8 |
| Tramadol | 38 | $110 | $3 |
| Terazosin | 12 | $92 | $8 |
| Alprazolam | 35 | $43 | $1 |
Year by year
| 2024 | 1,509 | 534 | 4% (62) | None | $145,578 |
| 2023 | 1,710 | 625 | 5% (89) | None | $176,517 |
| 2022 | 1,132 | 426 | 4% (48) | None | $136,390 |
| 2021 | 955 | 378 | 5% (47) | None | $123,179 |
| 2020 | 779 | 289 | 4% (32) | None | $81,236 |
| 2019 | 942 | 342 | 5% (51) | 19% | $95,020 |
| 2018 | 1,128 | 341 | 6% (71) | 21% | $91,880 |
| 2017 | 841 | 292 | 8% (65) | None | $72,504 |
| 2016 | 843 | 288 | 8% (65) | None | $69,515 |
| 2015 | 598 | 243 | 8% (47) | None | $40,925 |
| 2014 | 155 | 86 | 18% (28) | 7% | $4,889 |
| 2013 | 41 | 24 | 32% (13) | None | $795 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Myrbetriq | 101 | $93,188 | $923 |
| Gemtesa | 22 | $27,855 | $1,266 |
| Methenamine Hippurate | 83 | $13,305 | $160 |
| Tamsulosin | 465 | $9,249 | $20 |
| Oxybutynin Chloride Er | 147 | $5,548 | $38 |
| Finasteride | 90 | $2,121 | $24 |
| Nitrofurantoin Mono-Macro | 104 | $1,975 | $19 |
| Testosterone Cypionate | 17 | $1,428 | $84 |
| Estradiol | 16 | $1,345 | $84 |
| Sulfamethoxazole-Trimethoprim | 174 | $879 | $5 |
| Alfuzosin Hcl Er | 18 | $658 | $37 |
| Cephalexin | 37 | $556 | $15 |
| Amoxicillin-Clavulanate Potass | 43 | $470 | $11 |
| Ciprofloxacin | 57 | $393 | $7 |
| Doxazosin Mesylate | 12 | $369 | $31 |
| Doxycycline Monohydrate | 14 | $262 | $19 |
| Tramadol | 59 | $178 | $3 |
| Hydrocodone-Acetaminophen | 24 | $157 | $7 |
| Diazepam | 14 | $10 | $1 |
| Alprazolam | 13 | $8 | $1 |
2022: 18 drugs
| Myrbetriq | 137 | $86,857 | $634 |
| Methenamine Hippurate | 106 | $19,239 | $181 |
| Oxybutynin Chloride Er | 115 | $6,322 | $55 |
| Tamsulosin | 184 | $3,596 | $20 |
| Tolterodine Tartrate Er | 12 | $3,305 | $275 |
| Desmopressin Acetate | 18 | $2,894 | $161 |
| Potassium Citrate Er | 14 | $2,793 | $199 |
| Nitrofurantoin Mono-Macro | 79 | $2,009 | $25 |
| Estradiol | 14 | $1,572 | $112 |
| Testosterone Cypionate | 13 | $1,217 | $94 |
| Finasteride | 40 | $824 | $21 |
| Sulfamethoxazole-Trimethoprim | 135 | $559 | $4 |
| Amoxicillin-Clavulanate Potass | 41 | $540 | $13 |
| Ciprofloxacin | 33 | $266 | $8 |
| Cephalexin | 22 | $199 | $9 |
| Hydrocodone-Acetaminophen | 19 | $106 | $6 |
| Tramadol | 26 | $75 | $3 |
| Fluconazole | 13 | $33 | $3 |
2021: 15 drugs
| Myrbetriq | 165 | $93,252 | $565 |
| Methenamine Hippurate | 44 | $8,384 | $191 |
| Oxybutynin Chloride Er | 94 | $3,971 | $42 |
| Potassium Citrate Er | 17 | $3,492 | $205 |
| Tamsulosin | 125 | $2,502 | $20 |
| Nitrofurantoin Mono-Macro | 72 | $1,974 | $27 |
| Finasteride | 47 | $1,136 | $24 |
| Desmopressin Acetate | 15 | $908 | $61 |
| Sulfamethoxazole-Trimethoprim | 132 | $535 | $4 |
| Amoxicillin-Clavulanate Potass | 30 | $260 | $9 |
| Ciprofloxacin | 36 | $137 | $4 |
| Cephalexin | 14 | $136 | $10 |
| Hydrocodone-Acetaminophen | 19 | $133 | $7 |
| Fluconazole | 13 | $77 | $6 |
| Tramadol | 25 | $69 | $3 |
2020: 14 drugs
| Myrbetriq | 106 | $48,129 | $454 |
| Methenamine Hippurate | 31 | $5,831 | $188 |
| Oxybutynin Chloride Er | 111 | $4,567 | $41 |
| Tamsulosin | 118 | $2,613 | $22 |
| Desmopressin Acetate | 18 | $2,133 | $119 |
| Finasteride | 39 | $1,507 | $39 |
| Testosterone Cypionate | 12 | $1,488 | $124 |
| Nitrofurantoin Mono-Macro | 73 | $1,423 | $19 |
| Tolterodine Tartrate Er | 13 | $1,022 | $79 |
| Sulfamethoxazole-Trimethoprim | 66 | $299 | $5 |
| Ciprofloxacin | 31 | $189 | $6 |
| Amoxicillin-Clavulanate Potass | 25 | $159 | $6 |
| Hydrocodone-Acetaminophen | 12 | $83 | $7 |
| Tramadol | 18 | $54 | $3 |
2019: 18 drugs
| Myrbetriq | 67 | $38,964 | $582 |
| Methenamine Hippurate | 82 | $11,757 | $143 |
| Tamsulosin | 217 | $4,523 | $21 |
| Oxybutynin Chloride Er | 85 | $3,483 | $41 |
| Testosterone Cypionate | 27 | $2,343 | $87 |
| Desmopressin Acetate | 29 | $2,229 | $77 |
| Finasteride | 69 | $1,772 | $26 |
| Nitrofurantoin Mono-Macro | 52 | $1,122 | $22 |
| Dutasteride | 11 | $522 | $47 |
| Phenazopyridine | 14 | $522 | $37 |
| Sulfamethoxazole-Trimethoprim | 60 | $274 | $5 |
| Ciprofloxacin | 34 | $197 | $6 |
| Amoxicillin-Clavulanate Potass | 19 | $134 | $7 |
| Hydrocodone-Acetaminophen | 14 | $121 | $9 |
| Acetaminophen-Codeine | 16 | $91 | $6 |
| Tramadol | 21 | $74 | $4 |
| Cephalexin | 13 | $53 | $4 |
| Hydroxyzine | 12 | $47 | $4 |
2018: 19 drugs
| Myrbetriq | 81 | $39,840 | $492 |
| Methenamine Hippurate | 107 | $18,099 | $169 |
| Tamsulosin | 199 | $4,913 | $25 |
| Testosterone Cypionate | 57 | $3,387 | $59 |
| Desmopressin Acetate | 37 | $2,668 | $72 |
| Tolterodine Tartrate Er | 13 | $2,459 | $189 |
| Nitrofurantoin Mono-Macro | 85 | $2,197 | $26 |
| Oxybutynin Chloride Er | 39 | $2,079 | $53 |
| Finasteride | 51 | $819 | $16 |
| Phenazopyridine | 15 | $634 | $42 |
| Oxybutynin Chloride | 15 | $571 | $38 |
| Sulfamethoxazole-Trimethoprim | 113 | $546 | $5 |
| Amoxicillin-Clavulanate Potass | 57 | $381 | $7 |
| Ciprofloxacin | 62 | $316 | $5 |
| Acetaminophen-Codeine | 29 | $188 | $6 |
| Hydrocodone-Acetaminophen | 12 | $114 | $10 |
| Fluconazole | 21 | $109 | $5 |
| Tramadol | 30 | $95 | $3 |
| Levofloxacin | 12 | $35 | $3 |
2017: 15 drugs
| Myrbetriq | 44 | $31,378 | $713 |
| Methenamine Hippurate | 66 | $10,782 | $163 |
| Tamsulosin | 164 | $5,140 | $31 |
| Nitrofurantoin Mono-Macro | 92 | $2,409 | $26 |
| Desmopressin Acetate | 34 | $1,897 | $56 |
| Testosterone Cypionate | 30 | $1,858 | $62 |
| Oxybutynin Chloride Er | 32 | $1,488 | $47 |
| Finasteride | 19 | $414 | $22 |
| Sulfamethoxazole-Trimethoprim | 89 | $409 | $5 |
| Amoxicillin-Clavulanate Potass | 48 | $389 | $8 |
| Acetaminophen-Codeine | 30 | $259 | $9 |
| Ciprofloxacin | 44 | $218 | $5 |
| Hydrocodone-Acetaminophen | 17 | $174 | $10 |
| Tramadol | 17 | $58 | $3 |
| Cephalexin | 13 | $43 | $3 |
2016: 16 drugs
| Myrbetriq | 71 | $34,178 | $481 |
| Tamsulosin | 146 | $6,368 | $44 |
| Methenamine Hippurate | 29 | $2,139 | $74 |
| Nitrofurantoin Mono-Macro | 79 | $1,949 | $25 |
| Oxybutynin Chloride Er | 56 | $1,803 | $32 |
| Desmopressin Acetate | 28 | $1,720 | $61 |
| Testosterone Cypionate | 22 | $1,555 | $71 |
| Dutasteride | 17 | $1,031 | $61 |
| Finasteride | 36 | $702 | $19 |
| Ciprofloxacin | 65 | $344 | $5 |
| Sulfamethoxazole-Trimethoprim | 61 | $252 | $4 |
| Acetaminophen-Codeine | 29 | $212 | $7 |
| Hydrocodone-Acetaminophen | 16 | $209 | $13 |
| Amoxicillin-Clavulanate Potass | 15 | $127 | $8 |
| Tramadol | 20 | $101 | $5 |
| Fluconazole | 11 | $95 | $9 |
2015: 12 drugs
| Myrbetriq | 26 | $11,261 | $433 |
| Tamsulosin | 135 | $6,052 | $45 |
| Potassium Citrate Er | 12 | $2,584 | $215 |
| Nitrofurantoin Mono-Macro | 73 | $1,948 | $27 |
| Oxybutynin Chloride Er | 28 | $1,247 | $45 |
| Trospium Chloride | 14 | $925 | $66 |
| Desmopressin Acetate | 13 | $879 | $68 |
| Finasteride | 22 | $473 | $21 |
| Ciprofloxacin | 57 | $330 | $6 |
| Acetaminophen-Codeine | 31 | $204 | $7 |
| Sulfamethoxazole-Trimethoprim | 34 | $166 | $5 |
| Amoxicillin-Clavulanate Potass | 12 | $100 | $8 |
2014: 5 drugs
| Tamsulosin | 26 | $709 | $27 |
| Nitrofurantoin Mono-Macro | 18 | $493 | $27 |
| Hydrocodone-Acetaminophen | 16 | $168 | $10 |
| Ciprofloxacin | 29 | $132 | $5 |
| Sulfamethoxazole-Trimethoprim | 13 | $60 | $5 |
2013: 1 drug
| Hydrocodone-Acetaminophen | 12 | $113 | $9 |
Money from drug and device companies
$1,053 in 2025
| 2025 | 16 | 29 | None | $1,053 |
| 2024 | 17 | 42 | None | $1,424 |
| 2023 | 15 | 61 | None | $1,516 |
| 2022 | 12 | 20 | None | $1,284 |
| 2021 | 10 | 20 | None | $563 |
| 2020 | 4 | 9 | None | $506 |
| 2019 | 11 | 43 | None | $7,427 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sumitomo Pharma America | Gemtesa | $255 | 8 payments
|
| Ethicon US | Stratafix | $102 | 1 payment
|
| Abbvie | Botox | $98 | 5 payments
|
| Boston Scientific | Spaceoar Vue System - 10ml | $84 | 2 payments
|
| Pfizer | Xtandi | $72 | 1 payment
|
| Janssen Biotech | Rybrevant | $69 | 1 payment
|
See all 29 published payments
| Boston Scientific | Meals · 2025-12-16 | Spaceoar Vue System - 10ml | $49 |
| Abbvie | Meals · 2025-12-09 | Lupron Depot | $14 |
| Urogen Pharma | Meals · 2025-11-20 | Zusduri | $24 |
| Vertex Pharmaceuticals | Meals · 2025-11-14 | Journavx | $25 |
| Davol | Meals · 2025-10-08 | Arista | $38 |
| Sumitomo Pharma America | Meals · 2025-10-07 | Gemtesa | $43 |
| Abbvie | Meals · 2025-09-23 | Lupron Depot | $23 |
| Sumitomo Pharma America | Meals · 2025-08-12 | Gemtesa | $35 |
| Telix Pharmaceuticals | Meals · 2025-06-25 | Illuccix | $23 |
| Progenics Pharmaceuticals | Meals · 2025-06-12 | Pylarify | $23 |
| Telix Pharmaceuticals | Meals · 2025-05-27 | Illuccix | $27 |
| Sumitomo Pharma America | Meals · 2025-05-09 | Gemtesa | $35 |
| Sumitomo Pharma America | Meals · 2025-05-01 | Gemtesa | $2 |
| Boston Scientific | Meals · 2025-05-01 | Axonics | $35 |
| Sumitomo Pharma America | Meals · 2025-04-30 | Gemtesa | $41 |
| Pfizer | Meals · 2025-04-28 | Xtandi | $72 |
| Janssen Biotech | Meals · 2025-04-26 | Rybrevant | $69 |
| Smith+Nephew | Meals · 2025-04-22 | Stravix | $34 |
| Abbvie | Meals · 2025-04-11 | Botox | $18 |
| C. R. Bard Inc. & Subsidiaries | Meals · 2025-04-10 | Bard Urinary Drainage Bag | $38 |
| Laborie Medical Technologies | Meals · 2025-04-07 | Optilume Bph Drug Coated Balloon Catheter | $34 |
| Abbvie | Meals · 2025-03-18 | Botox | $20 |
| Sumitomo Pharma America | Meals · 2025-03-11 | Gemtesa | $27 |
| Sumitomo Pharma America | Meals · 2025-03-04 | Gemtesa | $36 |
| Olympus America | Meals · 2025-02-13 | Itind System | $61 |
| Sumitomo Pharma America | Meals · 2025-02-03 | Gemtesa | $35 |
| Ethicon US | Meals · 2025-01-28 | Stratafix | $102 |
| Abbvie | Meals · 2025-01-24 | Botox | $22 |
| Biotissue Holdings | Meals · 2025-01-06 | None | $47 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,424
| Sumitomo Pharma America | Gemtesa | $239 | 8 payments
|
| Abbvie | Botox | $171 | 8 payments
|
| Axonics | Axonics | $168 | 3 payments
|
| Laborie Medical Technologies | Optilume Bph Drug Coated Balloon Catheter | $147 | 2 payments
|
| Astellas Pharma Global Development | Xtandi | $130 | 1 payment
|
| Ferring Pharmaceuticals | Adstiladrin | $125 | 1 payment
|
| Ambu | None | $87 | 3 payments
|
| Becton Dickinson and | Bard Urinary Drainage Bag | $71 | 3 payments
|
| Pfizer | Xtandi | $50 | 3 payments
|
| Astellas Pharma US | Myrbetriq | $50 | 2 payments
|
| Endo USA | Xiaflex | $41 | 2 payments
|
| C. R. Bard Inc. & Subsidiaries | Bard Urinary Drainage Bag | $30 | 1 payment
|
| ConvaTec | Gentlecath Glide | $30 | 1 payment
|
| Telix Pharmaceuticals | Illuccix | $27 | 1 payment
|
| 180 Medical | Cure Catheter | $25 | 1 payment
|
| Biotissue Holdings | None | $19 | 1 payment
|
| Boston Scientific | Rezum Generator | $16 | 1 payment
|
2023: $1,516
| Sumitomo Pharma America | Gemtesa | $460 | 15 payments
|
| Axonics | Axonics | $150 | 6 payments
|
| Astellas Pharma US | Myrbetriq | $143 | 9 payments
|
| Boston Scientific | Rezum Generator | $133 | 4 payments
|
| AbbVie | Botox | $133 | 6 payments
|
| Endo Pharmaceuticals | Xiaflex | $128 | 7 payments
|
| Edap Technomed | None | $100 | 1 payment
|
| C. R. Bard Inc. & Subsidiaries | Bard Urinary Drainage Bag | $64 | 3 payments
|
| Blue Earth Diagnostics | Posluma | $55 | 3 payments
|
| Coloplast | Porges Coloplast | $37 | 2 payments
|
| Tolmar | Eligard | $30 | 1 payment
|
| Smith+Nephew | Stravix | $30 | 1 payment
|
| Supernus Pharmaceuticals | Xyosted | $20 | 1 payment
|
| Dentsply Ih Ab | Lofric | $18 | 1 payment
|
| Pfizer | Xtandi | $16 | 1 payment
|
2022: $1,284
| Axonics | Axonics | $777 | 5 payments
|
| Dornier MedTech America | Dornier Medtech | $145 | 1 payment
|
| Astellas Pharma US | Myrbetriq | $97 | 2 payments
|
| Abbvie | Lupron Depot | $62 | 3 payments
|
| Rochester Medical | None | $43 | 2 payments
|
| C. R. Bard Inc. & Subsidiaries | None | $34 | 1 payment
|
| Boston Scientific | General - Kidney Stone Disease | $29 | 1 payment
|
| Caldera Medical | Desara | $28 | 1 payment
|
| Teleflex | Urolift System | $21 | 1 payment
|
| Sagent Pharmaceuticals | Glydo | $18 | 1 payment
|
| Olympus America | Itind System | $15 | 1 payment
|
| UroGen Pharma | Jelmyto | $15 | 1 payment
|
2021: $563
| Janssen Biotech | Erleada | $168 | 2 payments
|
| AbbVie | Lupron Depot | $77 | 3 payments
|
| Coloplast | Altis | $70 | 2 payments
|
| Boston Scientific | Lithovue | $64 | 3 payments
|
| Ambu | None | $56 | 1 payment
|
| Axonics | Axonics R-Snm System | $42 | 2 payments
|
| Allergan | Botox | $32 | 2 payments
|
| Abbott Laboratories | Proclaim Ipg | $21 | 1 payment
|
| Rochester Medical | None | $19 | 1 payment
|
| Urogen Pharma | Jelmyto | $14 | 1 payment
|
2020: $506
| NeoTract | Urolift | $445 | 6 payments
|
| Rochester Medical | None | $23 | 1 payment
|
| Boston Scientific | Solyx | $21 | 1 payment
|
| AbbVie | Lupron Depot | $18 | 1 payment
|
2019: $7,427
| Coloplast | Altis | $6,151 | 7 payments
|
| Boston Scientific | Ams | $511 | 3 payments
|
| NeoTract | Urolift | $275 | 4 payments
|
| Astellas Pharma US | Xtandi | $128 | 9 payments
|
| Allergan | Botox | $122 | 6 payments
|
| Janssen Biotech | Erleada | $109 | 7 payments
|
| AbbVie | Lupron Depot | $35 | 2 payments
|
| Pfizer | Xtandi | $33 | 2 payments
|
| TherapeuticsMD | Imvexxy | $24 | 1 payment
|
| Avadel Specialty Pharmaceuticals | Noctiva | $23 | 1 payment
|
| Dendreon Pharmaceuticals | Provenge | $16 | 1 payment
|
Professional record
- NPI
- 1295980647
- Licence
- CA A157982, TX BP10029337California A157982: Current · expires 2028-08-31Texas BP10029337: Permit Terminated
- Trained
- Vanderbilt University School of Medicine, 2007 · 19 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2088F0040X (2088F0040X); Urology (208800000X)
- Mailing address
- 1240 S Eliseo Dr Ste 200, Greenbrae, CA, 94904
- NPI first listed
- 2008-11-26
- NPI last updated
- 2020-05-10
- NPI record certified
- 2020-05-10
This is when the NPI record was last certified, not a medical board exam.